Skip to content

    UPL

    UPL
    Chemicals·2 Feb 2026
    Management Summary

    UPL delivered a strong Q3 and 9M FY26 performance, marked by robust revenue and EBITDA growth, significant margin expansion, and substantial debt reduction. The company navigated macroeconomic headwinds and pricing pressures through effective execution and strategic initiatives, including new product launches and a disciplined approach to capital management. The filing of Advanta's DRHP signals a strategic move towards value unlocking and further deleveraging.

    Highlights

    6

    • Q3 FY26 Revenue of ₹12,269 crores, up 12% YoY, driven by 8% volume increase

    • Q3 FY26 Contribution Margin expanded 160 bps to 43%

    • Q3 FY26 EBITDA of ₹2,434 crores, up 13% YoY, achieving 20% margin

    • Q3 FY26 Profit Before Tax (PBT) jumped 90% YoY to ₹671 crores

    • Net debt reduced by over $400 million, leading to Net debt to EBITDA improvement from 3.8x to 2.5x

    • New product pipeline on track to exceed $130 million revenue target for the year

    Concerns

    4

    • Persistent pricing pressure in most molecules, limiting value recovery in the global crop protection market

    • Higher expected credit loss provisioning of ~$5 million in Q3 due due to liquidity stress on retailers/distributors in Latin America

    • Net working capital increased to 116 days (up 9 days YoY) as of Dec 31, 2025, due to higher sales and Q4 anticipation

    • US tariffs (50% on non-exempt products) continue to impact results, with a potential Q4 impact of over $30 million if tariffs persist

    Key financials

    Single quarter

    10 metrics
    1. 01Revenue₹12,269 Cr+12%YoY
    2. 02Contribution₹5,227 Cr+17%YoY
    3. 03Contribution Margin43%
    4. 04EBITDA₹2,434 Cr+13%YoY
    5. 05EBITDA Margin20%

    Segment breakdown

    UPL Corp (Global Crop Protection)
    8% Revenue Growth14.0% Contribution Growth6% EBITDA Growth19% EBITDA Margin
    UPL SAS (India Crop Protection)
    4% Revenue Growth800 bps Contribution Margin Improvement750 bps EBITDA Improvement
    Advanta (Seeds & Post-Harvest)
    22% Revenue Growth14.0% Volume Expansion (Seeds)55% Contribution Margin22% EBITDA Increase
    SUPERFORM (Manufacturing & Super Specialty)
    -11% Revenue Decline42% Emerging Super Specialty Growth470 bps Contribution Margin Improvement120 bps EBITDA Margin Improvement
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Debt

    Net ₹23,317 crores · 2.5x EBITDA

    M&A

    Advanta

    divestment · pending regulatory

    Liquidity

    Cash USD 570 million · Undrawn USD 1.7 billion

    Expected cash release of ~$700-800 million in Q4 FY26, combined with opening cash and unutilized credit lines, is sufficient to meet March and September 2026 debt maturities.

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    Revenue Growth
    4-8%
    		High
    Revenue
    New Product Launches Revenue
    >$130 million
    		High
    Profitability
    EBITDA Growth
    12-16%
    		High
    Working Capital
    Net Working Capital Days
    ~70 days
    		High
    Debt
    Net Debt to EBITDA
    1.6-1.8x
    		High

    Q4 FY26 Revenue Growth

    Next quarter (Q4 FY26 results)
    Current9M FY26 revenue growth 8%
    TargetImplied Q4 growth to reach 4-8% for FY26

    Why it matters

    Verifies the company's ability to maintain momentum and meet full-year top-line targets despite Q4 being a strong base last year.

    Now coming to your first question, just in terms of guidance, as we said, we're maintaining our guidance. Obviously, you can compute the numbers based on our results year-to-date.

    How to verify

    key_financials.metrics[label='Revenue']

    Risks & concerns

    4
    RiskSeverity

    Global Macroeconomic Headwinds

    Geopolitical uncertainties, shifting trade dynamics, continued tariff-driven volatility, pricing pressure, and softer commodity prices continue to pressure the crop protection value chain. — Management acknowledged

    medium

    China Overcapacity and Pricing Pressure

    Continued overcapacity in China contributes to low commodity prices for growers, impacting the market and leading to persistent pricing pressure in most molecules. — Management acknowledged

    medium

    LATAM Liquidity Stress and Expected Credit Losses (ECLs)

    Liquidity stress on retailers and distributors in Latin America resulted in higher expected credit loss provisioning, totaling approximately $5 million in Q3. — Management acknowledged

    medium

    US Tariffs

    Ongoing 50% tariffs on non-exempt products imported into the US continue to impact results, with a potential Q4 impact of over $30 million if tariffs persist, despite mitigation strategies like price increases and shifting to technical-grade imports. — Management acknowledged

    high

    Q&A highlights

    6

    “Now coming to your first question, just in terms of guidance, as we said, we're maintaining our guidance. Obviously, you can compute the numbers based on our results year-to-date. Again, the top line is just one component where obviously, we're focused on the bottom line. We're focused on cash generation. And so on every one of those metrics, including PBT, we're committed to driving very strong fourth quarter results.”

    Analyst questioned the implied slowdown in Q4 growth based on 9M performance and full-year guidance; management reiterated confidence in meeting targets by focusing on bottom line and cash, and confirmed Q4 growth across all regions.

    asked by Saurabh Jain

    2 min read6 chapters

    Detailed Narrative

    01

    Robust Q3 & 9M FY26 Performance Amidst Headwinds

    UPL delivered a strong Q3 FY26, with revenue growing 12% YoY to INR12,269 crores and EBITDA increasing 13% to INR2,434 crores, achieving a 20% margin. This performance was driven by an 8% volume increase and favorable exchange rates, despite persistent pricing pressure and macroeconomic uncertainties. For the nine months, revenue grew 8% and EBITDA surged 22% to INR5,941 crores, with a 200 bps margin improvement, showcasing resilience and effective execution.

    02

    Strategic Deleveraging and Improved Gearing Ratios

    The company significantly reduced its net debt by over $400 million (or $800 million adjusting for perpetual bonds) to $2.594 billion as of December 31, 2025. This led to a substantial improvement in gearing ratios, with net debt to EBITDA falling from 3.8x to 2.5x and net debt to equity from 0.8x to 0.6x. Management expressed confidence in meeting upcoming debt maturities of ~$500 million in March and ~$400 million in September 2026, supported by a strong Q4 cash release of ~$700-800 million and ample liquidity.

    03

    Advanta IPO for Value Creation and Deleveraging

    UPL filed the Draft Red Herring Prospectus (DRHP) for its seeds business, Advanta, on January 19, 2026. This move is an offer for sale, with proceeds flowing to selling shareholders (UPL and KKR) primarily for deleveraging UPL's balance sheet. The strategy aims to unlock value for shareholders, recognizing the distinct nature and growth trajectory of the seeds business compared to crop protection, similar to industry peers.

    04

    Platform-Specific Growth and Margin Expansion

    UPL Corp, the global crop protection business, grew 8% in Q3, expanding its contribution margin by 200 bps and EBITDA by 6%. India Crop Protection (UPL SAS) saw 4% revenue growth, with contribution margin improving by over 800 bps and EBITDA by 750 bps, reflecting sharper business hygiene. Advanta delivered a robust 22% revenue growth and 22% EBITDA increase, fueled by a 14% volume expansion in seeds. SUPERFORM, despite an 11% revenue decline due to phasing shifts and lower input costs, improved its contribution margin by 470 bps.

    05

    Navigating US Tariffs and Market Dynamics

    The company continues to face challenges from 50% US tariffs on certain imported products, which impacted Q3 EBITDA by an estimated ~$8 million YTD. To mitigate this, UPL is implementing price increases, shifting to importing technical-grade products for local formulation, and utilizing bonded warehouses. Management noted that ~$30 million in Q3 sales were purposely postponed to Q4, anticipating lower tariffs, which will now contribute to Q4 results.

    06

    Positive Outlook and FY26 Guidance Reaffirmed

    UPL reaffirmed its full-year FY26 guidance of 4-8% revenue growth and 12-16% EBITDA growth, building on the strong momentum from the first three quarters. The company anticipates a strong, volume-led Q4, supported by in-season demand and new product launches, which are on track to exceed $130 million in revenue this year. The focus remains on disciplined execution, prudent financial management, and sustainable value creation.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.